Asami Nishimori

A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma

Naoya Maekawa, Satoru Konnai, Satoshi Takagi et al. · Scientific Reports · 2017 · 157 citations · Full text

Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma

Naoya Maekawa, Satoru Konnai, Tomohiro Okagawa et al. · PLoS ONE · 2016 · 130 citations · Full text

Immunology, Immune Regulation, Pathology +20

Prostaglandin E2–Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti–PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection

Yamato Sajiki, Satoru Konnai, Tomohiro Okagawa et al. · The Journal of Immunology · 2019 · 48 citations · Full text

Bovine leukemia virus reduces anti‐viral cytokine activities and NK cytotoxicity by inducing TGF‐β secretion from regulatory T cells

Kosuke Ohira, Ayako Nakahara, Satoru Konnai et al. · Immunity Inflammation and Disease · 2016 · 47 citations · Full text

Tgf‐β Secretion, Laboratory Immunology, Lymphocyte Development +26

In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection

Asami Nishimori, Satoru Konnai, Tomohiro Okagawa et al. · PLoS ONE · 2017 · 43 citations · Full text

Veterinary Vaccine, Rat-bovine Chimeric Antibody, Immunology +17